Use of a microvascular coupler device for end-to-side venous anastomosis in oral and maxillofacial reconstruction
Use of a microvascular coupler device for end-to-side venous anastomosis in oral and maxillofacial reconstruction
复制标题
微血管耦合装置在口腔颌面重建中静脉端侧吻合术的应用
DOI：
10.1016/j.ijom.2018.04.012
复制
发表时间：
2018-10-01
影响因子：
2.4
通讯作者：
Jian, X. -C.
中科院分区：
文献类型：
--
作者：
Wang, W. -M.;Huang, L.;Jian, X. -C.
本研究的目的是比较在口腔颌面部重建的游离组织移植中使用微血管耦合器装置（MCD）进行端侧静脉吻合（ETS组）和静脉成形术联合MCD进行端端静脉吻合（埃特组），比较吻合时间和术后血管危象的发生率。ETS组包括22例患者，埃特组包括40例患者。收集并分析患者人口统计学数据、吻合时间、耦合器尺寸、微血管并发症和皮瓣存活率。在ETS组中，最合适的供体血管尺寸大于2 mm，从2 mm到4 mm不等。ETS组的平均吻合时间为3.35 ± 0.89 min，埃特组为7.80 ± 2.93 min;两组之间的差异具有统计学意义（p < 0.0001）。两组之间的并发症或结局无统计学显著差异。当供体血管直径大于2 mm时，采用ETS静脉吻合加MCD技术是一种较好的吻合选择。在静脉不匹配的病例中，与埃特静脉吻合加MCD相比，ETS静脉吻合加MCD可显著缩短静脉成形术后的吻合时间。
The aim of this study was to compare the use of a microvascular coupler device (MCD) for end-to-side venous anastomosis (ETS group) and phleboplasties combined with MCD for end-to-end venous anastomosis (ETE group) in free tissue transfer for oral and maxillofacial reconstruction, with regard to the anastomosis time and occurrence of postoperative vascular crisis. The ETS group included 22 patients and the ETE group included 40 patients. Patient demographic data, anastomotic time, coupler size, microvascular complications, and flap survival rates were collected and analyzed. In the ETS group, the most suitable donor vessel size was greater than 2 mm, varying from 2 mm to 4 mm. The average anastomosis time was 3.35 + 0.89 min in the ETS group and 7.80 +/- 2.93 min in the ETE group; the difference between the groups was statistically significant (p < 0.0001). There were no statistically significant differences in complications or outcomes between the two groups. The ETS venous anastomosis with MCD technique is a better choice for anastomosis when the donor vessel size is greater than 2 mm. In those cases with mismatched veins, ETS venous anastomosis with MCD could significantly reduce the anastomosis time compared to ETE venous anastomosis with MCD after phleboplasties.